Skip to content

Clinical trials

Recruiting Smoldering Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Smoldering Multiple Myeloma Status: Recruiting Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20161
20182
20191
20212
20225
20235
20244
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
Memorial Sloan Kettering Cancer Center2
Regeneron Pharmaceuticals2
University of Miami2
Azienda USL Reggio Emilia - IRCCS1
Ciceri Fabio1
Dana-Farber Cancer Institute1
ECOG-ACRIN Cancer Research Group1
Emory University1
European Myeloma Network B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Smoldering Multiple Myeloma28
Multiple Myeloma16
Monoclonal Gammopathy of Undetermined Significance14
Immunoglobulin Light-chain Amyloidosis3
Leukemia, Plasma Cell3
Amyloidosis2
Castleman Disease2
Cryoglobulinemia2
POEMS Syndrome2
Hematologic Neoplasms1

Trials

Showing 76 to 28 of 28. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.